Management of chronic central serous chorioretinopathy
Loading...
Date
2018-12
Journal Title
Journal ISSN
Volume Title
Publisher
All India Ophthalmological Society
Abstract
New treatment modalities for the management of central serous chorioretinopathy (CSC) now exist. While acute CSC generally resolves without the requirement for intervention, chronic CSC has been associated with persistent disruption in visual function. Current treatment approaches include photodynamic therapy, oral aldosterone antagonism and subthreshold multifocal laser. There has also been further investigation into a number of new treatments including antivascular endothelial growth factor treatment. Further investigation using developing optical coherence tomography imaging is helping to determine biomarkers of CSC activity, potential indicators of treatment response and indications of chronicity of disease activity. Further comparative study is required to determine the effectiveness of different forms of treatment in a range of patients with varied demographics, aetiology and chronicity of disease.
Description
Keywords
Central serous chorioretinopathy, eplerenone, photodynamic therapy, subthreshold laser
Citation
Hanumunthadu D, Tan AC, Singh SR, Sahu NK, Chhablani J. Management of chronic central serous chorioretinopathy. Indian Journal of Ophthalmology. 2018 Dec; 66(12): 1704-1714